Jane Street
PACB icon

Jane Street’s Pacific Biosciences PACB Stock Holding History

Jane Street’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$255K Sell
151,900
-26,600
-15% -$38.7K ﹤0.01% 9563
2026
Q1 		$236K Sell
178,500
-128,500
-42% -$230K ﹤0.01% 9770
2025
Q4 		$574K Buy
307,000
+16,800
+6% +$32.3K ﹤0.01% 7378
2025
Q3 		$371K Buy
290,200
+274,600
+1,760% +$372K ﹤0.01% 8489
2025
Q2 		$19.3K Sell
15,600
-425,100
-96% -$491K ﹤0.01% 9364
2025
Q1 		$520K Sell
440,700
-1,194,900
-73% -$1.83M ﹤0.01% 6793
2024
Q4 		$2.99M Buy
1,635,600
+1,546,600
+1,738% +$3.02M ﹤0.01% 3444
2024
Q3 		$151K Sell
89,000
-18,700
-17% -$30.7K ﹤0.01% 8814
2024
Q2 		$148K Buy
107,700
+89,500
+492% +$181K ﹤0.01% 8583
2024
Q1 		$68.3K Sell
18,200
-373,200
-95% -$2.19M ﹤0.01% 8674
2023
Q4 		$3.84M Buy
391,400
+44,700
+13% +$366K ﹤0.01% 3245
2023
Q3 		$2.89M Sell
346,700
-68,400
-16% -$782K ﹤0.01% 3432
2023
Q2 		$5.52M Buy
415,100
+86,700
+26% +$1.05M ﹤0.01% 2588
2023
Q1 		$3.8M Buy
328,400
+163,800
+100% +$1.63M ﹤0.01% 2813
2022
Q4 		$1.35M Sell
164,600
-17,300
-10% -$149K ﹤0.01% 4495
2022
Q3 		$1.06M Buy
181,900
+55,700
+44% +$320K ﹤0.01% 5320
2022
Q2 		$558K Sell
126,200
-317,900
-72% -$1.93M ﹤0.01% 6529
2022
Q1 		$4.04M Buy
444,100
+316,800
+249% +$3.65M ﹤0.01% 3407
2021
Q4 		$2.6M Sell
127,300
-57,400
-31% -$1.39M ﹤0.01% 3956
2021
Q3 		$4.72M Sell
184,700
-40,700
-18% -$1.21M ﹤0.01% 2833
2021
Q2 		$7.88M Sell
225,400
-240,000
-52% -$6.98M ﹤0.01% 1999
2021
Q1 		$15.5M Buy
465,400
+202,100
+77% +$7.07M 0.01% 1187
2020
Q4 		$6.83M Buy
+263,300
New +$4.47M ﹤0.01% 1758
2016
Q4 		– Sell
-10,100
Closed -$90K – 4453
2016
Q3 		$90K Sell
10,100
-100
-1% -$836 ﹤0.01% 3859
2016
Q2 		$72K Buy
+10,200
New +$93.2K ﹤0.01% 3930

Other funds holding PACB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Jane Street's PACB Position: Q2 2026 in Review

Jane Street reduced its Pacific Biosciences (PACB) stake by 98% in Q2 2026, selling an estimated $1.97M and leaving 31,971 shares worth $53.7K. The position accounts for ﹤0.01% of the portfolio, ranked #10904.

Jane Street first reported a position in PACB in Q3 2013 and has held it in 32 quarters since. The position peaked at $6.66M in Q1 2021. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • Jane Street held 31,971 shares of Pacific Biosciences worth $53.7K as of Q2 2026.
  • Jane Street sold 1,358,099 Pacific Biosciences shares in Q2 2026, an estimated $1.97M.
  • Pacific Biosciences made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #10904 holding.
  • Jane Street first reported a position in Pacific Biosciences in Q3 2013 and has held it in 32 quarters since.
  • Jane Street's Pacific Biosciences position peaked at $6.66M in Q1 2021.
  • 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.